289 related articles for article (PubMed ID: 29436482)
21. Expression of angiotensin II receptors in aldosterone-producing adenoma of the adrenal gland and their clinical significance.
Wu Z; Ni D; Yan Y; Li J; Wang B; Ouyang J; Zhang G; Ma X; Li H; Zhang X
J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):486-9. PubMed ID: 20714875
[TBL] [Abstract][Full Text] [Related]
22. MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2.
Zhang G; Zou X; Liu Q; Xie T; Huang R; Kang H; Lai C; Zhu J
Int J Exp Pathol; 2018 Apr; 99(2):77-86. PubMed ID: 29665181
[TBL] [Abstract][Full Text] [Related]
23. Endoplasmic Reticulum Chaperone Calmegin Is Upregulated in Aldosterone-Producing Adenoma and Associates With Aldosterone Production.
Itcho K; Oki K; Gomez-Sanchez CE; Gomez-Sanchez EP; Ohno H; Kobuke K; Nagano G; Yoshii Y; Baba R; Hattori N; Yoneda M
Hypertension; 2020 Feb; 75(2):492-499. PubMed ID: 31865789
[TBL] [Abstract][Full Text] [Related]
24. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
Nanba K; Tsuiki M; Sawai K; Mukai K; Nishimoto K; Usui T; Tagami T; Okuno H; Yamamoto T; Shimatsu A; Katabami T; Okumura A; Kawa G; Tanabe A; Naruse M
J Clin Endocrinol Metab; 2013 Apr; 98(4):1567-74. PubMed ID: 23443813
[TBL] [Abstract][Full Text] [Related]
25. Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas.
Fallo F; Pezzi V; Barzon L; Mulatero P; Veglio F; Sonino N; Mathis JM
Eur J Endocrinol; 2002 Dec; 147(6):795-802. PubMed ID: 12457455
[TBL] [Abstract][Full Text] [Related]
26. Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.
Guo Z; Nanba K; Udager A; McWhinney BC; Ungerer JPJ; Wolley M; Thuzar M; Gordon RD; Rainey WE; Stowasser M
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3224-35. PubMed ID: 32516371
[TBL] [Abstract][Full Text] [Related]
27. GRK2-Mediated Crosstalk Between β-Adrenergic and Angiotensin II Receptors Enhances Adrenocortical Aldosterone Production In Vitro and In Vivo.
Pollard CM; Ghandour J; Cora N; Perez A; Parker BM; Desimine VL; Wertz SL; Pereyra JM; Ferraino KE; Patel JJ; Lymperopoulos A
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963151
[TBL] [Abstract][Full Text] [Related]
28. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
Boulkroun S; Golib Dzib JF; Samson-Couterie B; Rosa FL; Rickard AJ; Meatchi T; Amar L; Benecke A; Zennaro MC
Mol Cell Endocrinol; 2013 May; 371(1-2):221-7. PubMed ID: 23376008
[TBL] [Abstract][Full Text] [Related]
29. Physiological and Pathological Roles in Human Adrenal of the Glomeruli-Defining Matrix Protein NPNT (Nephronectin).
Teo AE; Garg S; Johnson TI; Zhao W; Zhou J; Gomez-Sanchez CE; Gurnell M; Brown MJ
Hypertension; 2017 Jun; 69(6):1207-1216. PubMed ID: 28416583
[TBL] [Abstract][Full Text] [Related]
30. TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas.
Gong S; Tetti M; Kemter E; Peitzsch M; Mulatero P; Bidlingmaier M; Eisenhofer G; Wolf E; Reincke M; Williams TA
Hypertension; 2023 Feb; 80(2):440-450. PubMed ID: 36458545
[TBL] [Abstract][Full Text] [Related]
31. DNA Methylation of Steroidogenic Enzymes in Benign Adrenocortical Tumors: New Insights in Aldosterone-Producing Adenomas.
Di Dalmazi G; Morandi L; Rubin B; Pilon C; Asioli S; Vicennati V; De Leo A; Ambrosi F; Santini D; Pagotto U; Maffeis V; Fassina A; Fallo F
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32844182
[TBL] [Abstract][Full Text] [Related]
32. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
Choi M; Scholl UI; Yue P; Björklund P; Zhao B; Nelson-Williams C; Ji W; Cho Y; Patel A; Men CJ; Lolis E; Wisgerhof MV; Geller DS; Mane S; Hellman P; Westin G; Åkerström G; Wang W; Carling T; Lifton RP
Science; 2011 Feb; 331(6018):768-72. PubMed ID: 21311022
[TBL] [Abstract][Full Text] [Related]
33. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
Savoia C; Arrabito E; Parente R; Nicoletti C; Madaro L; Battistoni A; Filippini A; Steckelings UM; Touyz RM; Volpe M
Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664
[TBL] [Abstract][Full Text] [Related]
34. Mass Spectrometry Imaging Establishes 2 Distinct Metabolic Phenotypes of Aldosterone-Producing Cell Clusters in Primary Aldosteronism.
Sun N; Meyer LS; Feuchtinger A; Kunzke T; Knösel T; Reincke M; Walch A; Williams TA
Hypertension; 2020 Mar; 75(3):634-644. PubMed ID: 31957522
[TBL] [Abstract][Full Text] [Related]
35. Metallothionein-3 (MT-3) in the human adrenal cortex and its disorders.
Felizola SJ; Nakamura Y; Arata Y; Ise K; Satoh F; Rainey WE; Midorikawa S; Suzuki S; Sasano H
Endocr Pathol; 2014 Sep; 25(3):229-35. PubMed ID: 24242700
[TBL] [Abstract][Full Text] [Related]
36. The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma.
Oki K; Gomez-Sanchez CE
Endocr J; 2020 Oct; 67(10):989-995. PubMed ID: 32968034
[TBL] [Abstract][Full Text] [Related]
37. Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA).
Nakamura Y; Hattangady NG; Ye P; Satoh F; Morimoto R; Ito-Saito T; Sugawara A; Ohba K; Takahashi K; Rainey WE; Sasano H
Mol Cell Endocrinol; 2014 Mar; 384(1-2):102-8. PubMed ID: 24472523
[TBL] [Abstract][Full Text] [Related]
38. Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1.
Takeda Y; Demura M; Kometani M; Karashima S; Yoneda T; Takeda Y
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982850
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.
Gomez-Sanchez CE; Gomez-Sanchez EP; Nishimoto K
Horm Metab Res; 2020 Jun; 52(6):421-426. PubMed ID: 32289837
[TBL] [Abstract][Full Text] [Related]
40. Disordered CYP11B2 Expression in Primary Aldosteronism.
Gomez-Sanchez CE; Kuppusamy M; Reincke M; Williams TA
Horm Metab Res; 2017 Dec; 49(12):957-962. PubMed ID: 29202495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
